Stockreport

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors

Werewolf Therapeutics, Inc.  (HOWL) 
PDF WATERTOWN, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of c [Read more]